FDA Drug Application (020781) for ZOFRAN ODT by NOVARTIS PHARMS CORP

Back to FDA Applications sponsored by NOVARTIS PHARMS CORP

Application Number020781
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage4MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameZOFRAN ODT
Active IngredientONDANSETRON

Active IngredientCount
List of drugs with Active Ingredient ONDANSETRON3


Back to FDA Applications sponsored by NOVARTIS PHARMS CORP